Adjuvant hormonal therapy for early breast cancer: an epidemiologic study of medication adherence.

Date publication

mai 2018

Journal

Breast cancer research and treatment

Auteurs

Membres identifiés du Cancéropôle Est :
Dr CHAIGNEAU Loïc , Pr NERICH Virginie , Dr PAGET-BAILLY Sophie , Mme HENRIQUES Julie

Tous les auteurs :
Pourcelot C, Orillard E, Nallet G, Dirand C, Billion-Rey F, Barbier G, Chouk S, Limat S, Montcuquet P, Henriques J, Paget-Bailly S, Anota A, Chaigneau L, Nerich V

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/29362956

Résumé

The aim of this study was to determine the prevalence of adherence to adjuvant hormonal therapy (AHT) and to identify risk factors for medication non-adherence in clinical practice in patients with early-stage hormone receptor (HR)-positive breast cancer (BC) previously treated with chemotherapy.

Mots clés

Adjuvant hormonal therapy, Aromatase inhibitors, Breast cancer, Medication adherence, Tamoxifen

Référence

Breast Cancer Res. Treat.. 2018 May;169(1):153-162